AU Patent

AU2008229685B2 — 2,4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders

Assigned to Novartis AG · Expires 2011-07-28 · 15y expired

What this patent protects

Abstract Novel pyrimidine derivatives of formula I 1 R 5 R6R7 8 2 As R N N N R9 to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.

USPTO Abstract

Abstract Novel pyrimidine derivatives of formula I 1 R 5 R6R7 8 2 As R N N N R9 to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.

Drugs covered by this patent

Patent Metadata

Patent number
AU2008229685B2
Jurisdiction
AU
Classification
—
Expires
2011-07-28
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.